2020 Medicinal Chemistry Reviews
Volume 55
Joanne J. Bronson, Editor-In-Chief
Medicinal Chemistry Reviews is an outstanding 830 page volume providing timely and critical reviews of important topics in medicinal chemistry. It is provided free of charge to MEDI members in electronic format. Members can also order a print copy, for the cost of printing, shipping and handling (price to be determined).
Members: To access your copy:
--Click 'Member Login' in the upper right corner of this page
--On the Member Login page, click the 'Resources' tab.
Nonmembers wishing to purchase a copy may click here and purchase at the non-member price.
Libraries and institutions interested in purchasing a copy should contact the Division Secretary, secretary@acsmedchem.org.
Table of Contents:
Chapter 1 |
Drug Discovery: Ingenuity and Serendipity...Or is It the Other Way Around? |
Chapter 2 | |
Chapter 3 |
Recent Progress in Neuroinflammatory Drug Targets |
Chapter 4 |
Recent Progress in Kappa and Mu Opioid Receptor Targeted Ligands |
Chapter 5 | |
Chapter 6 | |
Chapter 7 |
Recent Advances in the Discovery of NLRP3 Inflammasome Inhibitors |
Chapter 8 | |
Chapter 9 |
TLR7, TLR8, and TLR9 Antagonists: Potential Therapies for Autoimmune Diseases |
Chapter 10 | |
Chapter 11 |
Allosteric Inhibition of SHP2 Phosphatase |
Chapter 12 | |
Chapter 13 | |
Chapter 14 | |
Chapter 15 | |
Chapter 16 | |
Chapter 17 |
Targeting Nuclear Export for Treatment of Cancers and Other Diseases |
Chapter 18 | |
Chapter 19 | |
Chapter 20 | |
Chapter 21 | |
Chapter 22 |
|
Chapter 23 | |
Chapter 24 | |
Chapter 25 | |
Chapter 26 | |
Chapter 27 | |
Chapter 28 |